Severe overdosage with the antiepileptic drug oxcarbazepineVAN OPSTAL, J. M; JANKNEGT, R; CILISSEN, J et al.British journal of clinical pharmacology. 2004, Vol 58, Num 3, pp 329-331, issn 0306-5251, 3 p.Article

LC method for the determination of oxcarbazepine in pharmaceutical preparationsQI, M. L; WANG, P; WANG, L. J et al.Journal of pharmaceutical and biomedical analysis. 2003, Vol 31, Num 1, pp 57-62, issn 0731-7085, 6 p.Article

Synthesis of S-licarbazepine by asymmetric reduction of oxcarbazepine with Saccharomyces cerevisiae CGMCC No. 2266OU, Zhi-Min; SHI, Han-Bing; SUN, Xing-Yuan et al.Journal of molecular catalysis. B, Enzymatic. 2011, Vol 72, Num 3-4, pp 294-297, issn 1381-1177, 4 p.Article

Objective assessment of neurotoxicity while shifting from carbamazepine to oxcarbazepineCLEMENS, B; MANES, A; NAGY, Z et al.Acta neurologica scandinavica. 2004, Vol 109, Num 5, pp 324-329, issn 0001-6314, 6 p.Article

The effect of oxcarbazepine in peripheral neuropathic pain depends on pain phenotype: A randomised, double-blind, placebo-controlled phenotype-stratified studyDEMANT, Dyveke T; LUND, Karen; VOLLERT, Jan et al.Pain (Amsterdam). 2014, Vol 155, Num 11, pp 2263-2273, issn 0304-3959, 11 p.Article

Central hypothyroidism with oxcarbazepine therapyMILLER, Jennifer; CARNEY, Paul.Pediatric neurology. 2006, Vol 34, Num 3, pp 242-244, issn 0887-8994, 3 p.Article

Oxcarbazepine monotherapy in children and adolescents : A single-center clinical experienceKOTHARE, Sanjeev V; KHURANA, Divya S; MOSTOFI, Navid et al.Pediatric neurology. 2006, Vol 35, Num 4, pp 235-239, issn 0887-8994, 5 p.Article

Oxcarbazepine therapy in very young children : A single-center clinical experienceKOTHARE, Sanjeev V; MOSTOFI, Navid; KHURANA, Divya S et al.Pediatric neurology. 2006, Vol 35, Num 3, pp 173-176, issn 0887-8994, 4 p.Article

Oxcarbazepine in glossopharyngeal neuralgia: Clinical response and effect on serum lipidsLUEF, Gerhard; POEWE, Werner.Neurology. 2004, Vol 63, Num 12, pp 2447-2448, issn 0028-3878, 2 p.Article

Avec du recul : Oxcarbazépine, des effets indésirables cutanés aussi : Les faits maquants 2004 = With the benefit of hindsight : Oxcarbazepine, cutaneous side-effects tooLa Revue Prescrire. 2004, Vol 24, Num 255, issn 0247-7750, p. 750Conference Paper

Fixed Drug Eruption on the Penis Due to OxcarbazepineSCHUSTER, Christian; KRÄNKE, Birger; ABERER, Werner et al.Archives of dermatology (1960). 2011, Vol 147, Num 3, pp 362-364, issn 0003-987X, 3 p.Article

The suppressive effects of oxcarbazepine on mechanical and cold allodynia in a rat model of neuropathic painJANG, Yeon; KIM, Eun S; PARK, Soo S et al.Anesthesia and analgesia. 2005, Vol 101, Num 3, pp 800-806, issn 0003-2999, 7 p.Article

Efficacy of IT oxcarbazepine for prophylaxis against cumulative oxaliplatin-induced neuropathyARGYRIOU, A. A; CHRONI, E; POLYCHRONOPOULOS, P et al.Neurology. 2006, Vol 67, Num 12, pp 2253-2255, issn 0028-3878, 3 p.Article

Population pharmacokinetics of oxcarbazepine active metabolite in Chinese children with epilepsyJING PENG; ZHANG, Hua-Nian; LIU, Zhi-Sheng et al.International journal of clinical pharmacology and therapeutics. 2014, Vol 52, Num 8, pp 684-692, issn 0946-1965, 9 p.Article

Seizure deterioration in women treated with oxcarbazepine during pregnancyPETRENAITE, Vaiva; SABERS, Anne; HANSEN-SCHWARTZ, Jacob et al.Epilepsy research. 2009, Vol 84, Num 2-3, pp 245-249, issn 0920-1211, 5 p.Article

Short-term impact of the switch from immediate-release to extended-release oxcarbazepine in epilepsy patients on high dosagesSTEINHOFF, Bernhard J; WENDLING, Anne-Sophie.Epilepsy research. 2009, Vol 87, Num 2-3, pp 256-259, issn 0920-1211, 4 p.Article

Disposition of eslicarbazepine acetate in the mouse after oral administrationALVES, Gilberto; FIGUEIREDO, Isabel; CASTEL-BRANCO, Margarida et al.Fundamental & clinical pharmacology. 2008, Vol 22, Num 5, pp 529-536, issn 0767-3981, 8 p.Article

Investigations on factors affecting chitosan for dissolution enhancement of oxcarbazepine by spray dried microcrystal formulation with an experimental design approachRANE, Yogesh M; MASHRU, Rajshree C; SANKALIA, Mayur G et al.Drug development and industrial pharmacy. 2007, Vol 33, Num 9, pp 1008-1023, issn 0363-9045, 16 p.Article

Rationale and evidence for the use of oxcarbazepine in neuropathic painCARRAZANA, Enrique; MIKOSHIBA, Imao.Journal of pain and symptom management. 2003, Vol 25, Num 5, pp S31-S35, issn 0885-3924, SUPArticle

Oxidation of antiepileptic drug oxcarbazepine stimulated by thermally activated persulfateCHANGZHENG CUI; ZHAORONG YANG; ZHONGXIN ZHOU et al.International journal of environmental technology and management. 2014, Vol 17, Num 5, pp 418-429, issn 1466-2132, 12 p.Article

A novel enantioselective microassay for the high-performance liquid chromatography determination of oxcarbazepine and its active metabolite monohydroxycarbazepine in human plasmaMAZZUCCHELLI, Iolanda; BSC; FRANCO, Valentina et al.Therapeutic drug monitoring. 2007, Vol 29, Num 3, pp 319-324, issn 0163-4356, 6 p.Article

Comparison of two anticonvulsants in a randomized, single-blind treatment of hypomanic symptoms in patients with bipolar disorderSUPPES, Trisha; KELLY, Dorothy I; HYNAN, Linda S et al.Australian and New Zealand journal of psychiatry. 2007, Vol 41, Num 5, pp 397-402, issn 0004-8674, 6 p.Article

Epilepsy and pregnancy: lamotrigine as main drug usedSABERS, A; DAM, M; A-ROGVI-HANSEN, B et al.Acta neurologica scandinavica. 2004, Vol 109, Num 1, pp 9-13, issn 0001-6314, 5 p.Article

Efficacy of oxcarbazepine in the treatment of painful diabetic neuropathyBEYDOUN, Ahmad; KOBETZ, Steven A; CARRAZANA, Enrique J et al.The Clinical journal of pain. 2004, Vol 20, Num 3, pp 174-178, issn 0749-8047, 5 p.Article

Effects of charcoal on the absorption and elimination of the antiepileptic drugs lamotrigine and oxcarbazepineKERÄNEN, Tapani; SORRI, Annamari; MOILANEN, Eeva et al.Arzneimittel-Forschung. 2010, Vol 60, Num 7, pp 421-426, issn 0004-4172, 6 p.Article